MARSHALL WACE, LLP - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 39 filers reported holding GALERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$993,788
+112.5%
318,522
+74.4%
0.00%
+100.0%
Q1 2023$467,633
+987.5%
182,669
+914.6%
0.00%
Q1 2022$43,000
-48.8%
18,004
-2.1%
0.00%
Q4 2021$84,000
-87.5%
18,382
-77.9%
0.00%
-100.0%
Q3 2021$673,000
-41.2%
83,050
-28.7%
0.00%
-40.0%
Q2 2021$1,145,000
+139.5%
116,508
+115.3%
0.01%
+150.0%
Q1 2021$478,00054,1140.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 613,223$2,815,0000.83%
Sofinnova Investments, Inc. 3,083,712$14,154,0000.83%
Novo Holdings A/S 2,459,021$11,287,0000.53%
ACUTA CAPITAL PARTNERS, LLC 262,500$1,205,0000.51%
Tekla Capital Management LLC 898,374$4,124,0000.13%
Aristides Capital LLC 20,000$92,0000.04%
XTX Topco Ltd 13,499$62,0000.04%
Blackstone Inc. 1,678,984$7,707,0000.02%
Taylor Wealth Management Partners 11,635$53,0000.02%
Belvedere Trading LLC 96,486$255,0000.01%
View complete list of GALERA THERAPEUTICS INC shareholders